The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
One of the AI haves feels the pain of the AI have-nots.His discomfort is especially pronounced when he thinks about how hard it must be for financial strugglers to keep up with regulations and rumors of regulations to come.
It's slated to become the 31st state to finalize legislation eliminating out-of-pocket costs for follow-up exams after an abnormal screening mammogram.
Last month, the insurance giant announced it will begin charging hospitals a 10% administrative penalty for claims that involve docs outside of its networks.
The country’s largest imaging group is buying Palo Alto, California-based Cognita Imaging Inc., which was founded by scientists at Stanford University.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
